The combination effect of vitamin K and vitamin D on human bone quality: A meta-analysis of randomized controlled trials
The Science Behind Ozempic, Wegovy, and Other GLP-1 Medications Medicines like Ozempic and Wegovy work by activating GLP-1 receptors
Retatrutide is an investigational GLP-1, GIP, and glucagon triple receptor agonist that has not received MHRA or EMA approval and holds no UK marketing authorisation
What the Evidence Shows (and What It Doesnt) A recent real-world study (n = 94) on semaglutide + cyanocobalamin (compounded) showed average weight loss of ~4.11 kg (4.6%) in 3 months , along with favorable reductions in fat mass and improvements in body composition PubMed However, large controlled trials of this exact combination are lacking
According to the International Diabetes Federation (IDF), about 537 million people worldwide have diabetes, with 90% being T2D
Most patients experience little to no side effects